The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index; 15 of the 188 sources its claims cite were checked for support.
Top-down proteomics: challenges, innovations, and applications in basic and clinical research
Open accessAbstract
Introduction- A better understanding of the underlying molecular mechanism of diseases is critical for developing more effective diagnostic tools and therapeutics toward precision medicine. However, many challenges remain to unravel the complex nature of diseases.Areas covered- Changes in protein isoform expression and post-translation modifications (PTMs) have gained recognition for their role in underlying disease mechanisms. Top-down mass spectrometry (MS)-based proteomics is increasingly recognized as an important method for the comprehensive characterization of proteoforms that arise from alternative splicing events and/or PTMs for basic and clinical research. Here, we review the challenges, technological innovations, and recent studies that utilize top-down proteomics to elucidate changes in the proteome with an emphasis on its use to study heart diseases.Expert opinion- Proteoform-resolved information can substantially contribute to the understanding of the molecular mechanisms underlying various diseases and for the identification of novel proteoform targets for better therapeutic development . Despite the challenges of sequencing intact proteins, top-down proteomics has enabled a wealth of information regarding protein isoform switching and changes in PTMs. Continuous developments in sample preparation, intact protein separation, and instrumentation for top-down MS have broadened its capabilities to characterize proteoforms from a range of samples on an increasingly global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
127 Not checked yet · 5 Own interpretation · 5 No basis given · 4 Supported · 4 Partly supported · 2 Supported so far · accuracy not yet measured
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Mutations, alternative splicing events, and post-translational modifications (PTMs) result in a host of proteoforms (a term referring to all the protein products that arise from a single gene) that greatly diversify the proteome [1–4].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Introduction
What the sources say
- Supportedcites [1] source
The opening section of “Proteoforms as the next proteomics currency” (page not provided) defines proteoforms as forms arising from sequence variations, splice isoforms, and posttranslational modifications. It also describes these sources of variation as creating a complex diversity of proteins, supporting the citing sentence’s paraphrase. (LLM, conf=0.91)
- Not checked yetcites [2] source
- Supportedcites [3] source
In “To the Editor,” the paper says protein complexity arises from allelic variation, alternative RNA splicing, and post-translational modifications. It defines proteoforms as the different molecular forms of a single gene’s protein product, including forms arising from genetic variation, splicing, and PTMs. (LLM, conf=0.94)
- Supportedcites [4] source
Figure 2 (p. 20) says that alternatively spliced isoforms and site-specific changes, including SNPs and PTMs, combine to generate proteoforms that map back to a single gene. Figure 3 (p. 24) also identifies mutations, alternative splicing, and PTMs as sources of protein variability. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Liang et al. demonstrated that bridged hybrid bis(triethoxysilyl)ethylene monolith with C8 functional groups afforded high-resolution separation of complex cardiac lysate including a large proteoform, α-actinin2 (103.77 kDa) [72].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Supportedcites [72] source
The Abstract identifies the column as a bridged hybrid bis(triethoxysilyl)ethylene monolith with C8 functional groups. It reports effective separation of a complex protein mixture from swine cardiac tissue and identification of α-actinin2 (103.77 kDa) among the proteoforms. (LLM, conf=0.94)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“While around 1,400 mutations have been identified in 11 genes related to the sarcomere, the molecular events leading to disease phenotype remain largely misunderstood [148].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Partly supportedcites [148] sourceExperimental — accuracy not yet measured
The Conclusions and Future Directions section says that important molecular mechanisms remain unresolved, including how sarcomere changes cause cell enlargement and fibrosis. That supports the quoted point about the HCM phenotype. The same citation is attached to the full sentence, however, and the Molecular Genetics section reports more than 1,000 rare pathogenic variants in HCM and DCM, not the stated figure of around 1,400 mutations in 11 sarcomere genes; those exact numbers are not supported by our copy. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Their results convincingly show that regardless of the HCM causing mutation, convergent sarcomeric proteoforms were observed in the HCM samples compared to the donor samples.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Supportedcites [149] source
The Discussion (‘Converging Sarcomeric Proteoform Profiles in HCM’) reports uniform proteoform changes between the control and HCM groups regardless of the specific mutation in the samples studied. The authors limit this finding to the obstructive HCM tissues and genotypes they analyzed; the claim describes those samples rather than all HCM patients. (LLM, conf=0.91)
boostedn = 16- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Undoubtedly, the advancement of top-down proteomics is stimulated by the commercial growth of large molecule therapeutics such as monoclonal antibodies and antibody-drug-conjugates as detailed and high-throughput methods for their characterization and quality control are required [81,159,160].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Partly supportedcites [81] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [159] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [160] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“However, the ‘peptide-to-protein inference’ problem in bottom-up proteomics leads to a loss in proteoform information because of many homologous sequence regions are shared between different protein forms and the generally low protein sequence coverage is observed [13,14].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Introduction
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“To standardize sample preparation, a “best practices and benchmarks” was reported by Agar and colleagues in the Consortium of Top-down Proteomics [23].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
What the sources say
- Not checked yetcites [23] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Mass spectrometry (MS)-based proteomics has emerged as the most versatile and comprehensive strategy for protein characterization [8,9].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Introduction
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Moreover, mutations and differential expression of protein isoforms have been shown to drive molecular mechanisms underlying disease phenotypes, necessitating their in-depth characterization [5,7].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Introduction
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, most salts and conventional surfactants are generally incompatible with MS analysis and must be removed before downstream analysis [22].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
What the sources say
- Not checked yetcites [22] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 55
- Probably not a substantial claim. 24
- The quote only partly states this claim. 1
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although long columns (>1 m) were demonstrated to provide a peak capacity of >400 and confidently identified ~900 proteoforms, they operate at ultrahigh pressures (~14,000 psi) and are not always practical [70].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Partly supportedcites [70] sourceExperimental — accuracy not yet measured
The abstract (p. 1) reports peak capacities above 400 at 14,000 psi, and the Discussion (p. 11) reports assignment of approximately 900 proteoforms at 1% FDR. However, the paper does not link that assignment specifically to columns longer than 1 m. Its Methods (p. 2) say the 14,000-psi approach can be readily implemented on commercial systems; the Conclusions (p. 11) reserve the practical-instrument limitation for long columns packed with smaller particles that require still higher pressures. (LLM, conf=0.86)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Another emerging technique is liquid extraction surface analysis (LESA), which directly sampling proteins from a solid surface for analysis of protein and protein complexes [94,95].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Instrumentation and Fragmentation for Proteoform Identification and Characterization
What the sources say
- Partly supportedcites [94] sourceExperimental — accuracy not yet measured
The Introduction describes LESA extracting proteins directly from sampled surfaces, and the Conclusions report analysis of intact proteins from bacterial colonies. Our copy does not report LESA analysis of protein complexes; its mentions of complexes are in references to other studies. (LLM, conf=0.87)
- Supportedcites [95] source
The Introduction describes LESA sampling discrete locations on a surface with a solvent droplet before mass-spectrometry analysis of intact proteins. The Conclusions report successful LESA analysis of protein species on glass substrates, including protein complexes up to approximately 800 kDa. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“THRASH uses a theoretical isotopomer envelope based on the average elemental composition of amino acids (averagine) [125] to compare to the experimental envelopes. A statistical score is then assigned based on the overlap of the experimental and theoretical fit.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Data Acquisition and Analysis
What the sources say
- Supportedcites [125] source
The citation is attached to “averagine.” Results and Discussion (pp. 2–3) defines averagine as an average amino-acid composition, uses it to construct a theoretical isotopic profile, and describes statistical comparison with an experimental profile. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“circulating cTnI released into the blood upon myocardial infarction is a known cardiac protein biomarker [144–146].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Not checked yetcites [144] source
- Supportedcites [145] source
The Introduction identifies cTnI as a cardiac-specific protein released into circulation upon cardiomyocyte injury and used as a diagnostic biomarker of myocardial infarction. The “High sensitivity cTnI platforms” section explicitly states that cTnI is released into circulation during MI. (LLM, conf=0.95)
- Not checked yetcites [146] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The effects of aging, or sarcopenia, has detrimental effects on skeletal muscle due to the deterioration of muscle mass [152].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Supportedcites [152] source
The Sarcopenia section describes sarcopenia as an age-related decline in muscle mass, strength, and quality. The section on age-related changes in muscle contractility also links loss of muscle mass to loss of muscle force, supporting the citing sentence’s broad point. (LLM, conf=0.91)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
In the paper
“Using their outlined approach, incompatible salts and other components are removed from target proteins by ultrafiltration spin filters with specific molecular weight cutoffs to exchange MS-incompatible components for low concentration organic acid or volatile ammonium-based salts before analysis.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
What the sources say
- Not checked yetcites [23] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“This “bottom-up” proteomics approach is conventional as peptides, resulting from intact protein digestion, are biochemically more soluble, easier to separate, and there is numerous well-developed bioinformatics software available for protein identification and quantification [10].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Introduction
What the sources say
- Not checked yetcites [10] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“For this reason, the “top-down” proteomics approach, which forgoes digestion to peptides and instead analyzes intact proteins, is the preferred method to achieve unambiguous, proteoform-resolved molecular detail (Figure 1) [15].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Introduction
What the sources say
- Not checked yetcites [15] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Brown et al. have recently developed a photocleavable ionic surfactant, 4-hexylphenylazosulfonate (Azo) [31], which shows comparable protein extraction efficiency to common surfactants such as SDS and was compatible with top-down MS analysis after rapid UV-degradation (Figure 2) [31].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
What the sources say
- Not checked yetcites [31] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Additionally, Azo was shown to enable rapid enzymatic digestion by trypsin, demonstrating its unique ability as an “all-in-one” surfactant for integrated top-down and bottom-up proteomics [36].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
What the sources say
- Not checked yetcites [36] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, precipitation can be time-consuming and may add unintended sample variability and sample loss, as some proteins are not readily re-solubilized [26,27].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Briefly, native top-down MS involves using non-denaturing conditions and often employing 100–200 mM ammonium acetate as a volatile buffer for the analysis of intact proteins and protein complexes.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In this case, the entire protein-micelle complex is ionized, and the protein is liberated from the surfactant micelle using high collisional energy in the mass spectrometer [49].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
What the sources say
- Not checked yetcites [49] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Valuable information regarding protein complex subunit stoichiometry [42], metal-binding [43,44], protein interaction partners [45], and lipid binding [46] can be achieved using native MS.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The nanoPOTs technology, although still highly specialized, shows enormous promise to enable highly sensitive top-down proteomics (potentially even single-cell top-down analysis), but the majority of protein identifications were limited to sizes <10 kDa.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Sample Preparation for Top-down Proteomics
What the sources say
- Not checked yetcites [38] source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“On the other hand, monolithic columns offer high-resolution protein separation with low backpressure [71].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [71] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“More recently, the synthetic scalability, reproducibility, and enrichment efficacy of these NPs were improved using surface-silanized superparamagnetic magnetite (Fe3O4) particles coupled with the GAPT-Zn ligand [58].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein and Proteoform Enrichment for Top-down Proteomics
What the sources say
- Not checked yetcites [58] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“cardiac troponin I (cTnI) [65–67], an important and gold-standard cardiac biomarker [68].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein and Proteoform Enrichment for Top-down Proteomics
What the sources say
- Not checked yetcites [68] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The NP-peptide approach enabled the enrichment of cTnI with high specificity (< 1 ng/mL) and reproducibility, while at the same time depleted highly abundant proteins like human serum albumin.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein and Proteoform Enrichment for Top-down Proteomics
What the sources say
- Not checked yetcites [68] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Typically a single-dimension of RPLC can only enable the identification of ~100 intact proteoforms with limited coverage of larger species (>30 kDa) [69].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [69] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, antibodies possess many inherent limitations: batch-to-batch variation, high cost of production, poor chemical stability, and lack of proteoform-specific epitope recognition that collectively contribute to reproducibility issues [62–64].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein and Proteoform Enrichment for Top-down Proteomics
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“More recently, Gargano et al. developed online capillary HILIC for top-down proteomics [76].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [76] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Notably, they utilized a C4 trap column for loading (bypassing the traditional use of high organic solvent for sample composition) and doped propionic acid in the electrospray interface to overcome the signal suppression of trifluoroacetic acid in the mobile phase [76].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [76] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“To address these major issues, the Sun group optimized the dynamic pH junction CZE method, using 10% acetic acid as the background electrolyte, to load ~1 μL of sample and they demonstrated the use of single-shot CZE-MS analysis to identify ~600 proteoforms from an Escherichia coli lysate [74].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [74] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Chen et al. demonstrated online HIC-MS analysis for determination of the relative hydrophobicity, intact masses, and glycosylations of monoclonal antibodies (mAb) as well as gaining sequence and structural information using MS/MS [81].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [81] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“For example, online size exclusion chromatography (SEC) has been used for the rapid online desalting of antibodies and protein complexes [77].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [77] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Similarly, ion-exchange chromatography (IEX)-MS has been used to characterize protein conjugates [78,79].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“However, the proteome coverage was limited and significant work will still be needed before the full potential of HILIC for top-down proteomics is recognized.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [76] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“For example, native SEC and CZE were coupled to identify 672 proteoforms, 144 proteins, and 23 protein complexes [88].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [88] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Often large proteins, which have an inherently lower signal-to-noise, are underrepresented in top-down studies [83].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [83] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“More recently, PEPPI (passively eluting protein from polyacrylamide gel as intact species)-MS was introduced as an alternative gel-based separation technique [85].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [85] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“To bypass the use of SDS for separation, serial SEC (sSEC) was developed by coupling columns with differing pore sizes and using an MS-compatible mobile phase (1% formic acid).”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Using PEPPI, good protein recovery, and high-resolution separation was achieved for top-down proteomics of protein <50 kDa.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [85] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“sSEC was used to achieve high-resolution size-based separation of cardiac sarcomere proteins and, when used as for offline fractionation before RPLC-MS, enabled the detection of ~4,000 unique proteoforms up to 223 kDa [69].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
What the sources say
- Not checked yetcites [69] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Despite the advancements in multidimensional separation strategies, performing offline protein fractionation remains labor-intensive, low-throughput, and requires relatively large sample quantities making it not suitable for sample limited applications.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Quadrupole time-of-flight (q-TOF) mass spectrometers are a common alternative instrument platform, as they are robust, affordable, and capable of analyzing relatively large protein species [69,97].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Instrumentation and Fragmentation for Proteoform Identification and Characterization
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Although several ionization techniques are available, ESI is still predominately utilized for top-down proteomics as it is easy to interface with common LC systems [92].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Instrumentation and Fragmentation for Proteoform Identification and Characterization
What the sources say
- Not checked yetcites [92] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Currently, benchtop Orbitrap mass spectrometers are the most common instrument for proteomics as they bypass the need for cryogenic cooling (which is needed for the magnets of FTICR instruments) while still offering high-resolution and faster acquisition speeds [98,99].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Instrumentation and Fragmentation for Proteoform Identification and Characterization
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Traditionally, Fourier-transform ion cyclotron resonance (FTICR) mass spectrometers are the instrument of choice for top-down because of its capabilities to resolve very large species [96]; however, the slower scan speed can limit its capabilities for effective LC-MS/MS analysis and global protein characterization.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Instrumentation and Fragmentation for Proteoform Identification and Characterization
What the sources say
- Not checked yetcites [96] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Additionally, Kafader et. al demonstrated increase sensitivity and sequence coverage when employing CDMS of intact protein analysis [107].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Instrumentation and Fragmentation for Proteoform Identification and Characterization
What the sources say
- Not checked yetcites [107] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The major advantage of CDMS is the analysis of very large biomolecules including virus particles (2.47 MDa) and highly complex intact protein mixtures [108,109].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Instrumentation and Fragmentation for Proteoform Identification and Characterization
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Similarly, proton transfer reaction (PTR) MS has been used to reduce the average number of charge states for improved signal-to-noise and reduced spectral complexity for the identification of protein complex mixtures [106].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Instrumentation and Fragmentation for Proteoform Identification and Characterization
What the sources say
- Not checked yetcites [106] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Generally, data acquisition in top-down on an LC-MS timescale is performed using data-dependent acquisition (DDA) wherein the topmost intense peaks in the initial MS scan are selected for fragmentation [113].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [113] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Breakages along the protein backbone occur more randomly enabling higher sequence coverage while preserving labile PTMs.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [112] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“For example, Riley et al. demonstrated AI-ETD could identify 935 proteoforms while HCD, ETD, and EThcD identified 1014 proteoforms, 915, and 817, respectively [121].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [121] source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Predominately, UVPD breaks the bond between the alpha carbon and the carbonyl, resulting in a/x ions, but also can produce b/y and c/z ions.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Despite the challenges of sequencing intact proteins, top-down proteomics has enabled a wealth of information regarding protein isoform switching and changes in PTMs.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Abstract > Expert Opinion-
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
In the paper
“The diversity of bond breakages afforded by UVPD makes it ideal for deep sequence coverage, but higher numbers of protein identifications are still obtained using HCD for global top-down analysis by LC-MS [117].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [117] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“However, because CAD and HCD often break the most labile bonds, it may cleave labile PTMs (e.g., phosphorylation) and cause unwanted neutral loss of water and ammonium [112].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [112] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Continuous developments in sample preparation, intact protein separation, and instrumentation for top-down MS have broadened its capabilities to characterize proteoforms from a range of samples on an increasingly global scale.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Abstract > Expert Opinion-
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Proteoform-resolved information can substantially contribute to the understanding of the molecular mechanisms underlying various diseases and for the identification of novel proteoform targets for better therapeutic development toward precision medicine.”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Abstract > Expert Opinion-
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds. It may state two separate claims as one.
- Rests on an assumption: Many diseases have complex molecular mechanisms that remain poorly understood.
- Rests on an assumption: Improved understanding of disease mechanisms is necessary for developing more effective diagnostics and therapeutics for precision medicine.
In the paper
“Recently, electron ionization dissociation (EID), which uses high energy electrons for fragmentation, has shown promise for improved internal fragmentation for higher sequence coverage [116].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [116] Zenaidee M, 2020, Internal fragments generated by electron ionization dissociation enhances protein top-down mass spectrometry. J. Am. Soc. Mass Spectrom
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Ultraviolet photodissociation (UVPD) also preserves labile modification, but unlike ECD and ETD, it is charge state independent [20].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [20] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“However, the slower reaction kinetics, protein-to-protein variability, and charge state dependence of these techniques limit their application for global proteomic analysis[112].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [112] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“UniDec was developed to handle highly heterogeneous spectra, which has been critical for the interpretation of native protein mass spectra [127].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Data Acquisition and Analysis
What the sources say
- Not checked yetcites [127] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Thorough High-Resolution Analysis of Spectra by Horn (THRASH) was the first software to automate the deconvolution of high-resolution mass spectra and is still widely used [124].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Data Acquisition and Analysis
What the sources say
- Not checked yetcites [124] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Overall, the growing number of different fragmentation tools available has enabled high protein sequence coverage, improved global proteoform characterization, and characterization of higher-order protein structure [112].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [112] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“On the other hand, MS-Deconv generates a large set of candidate isotopomer envelopes and scores sets of envelopes rather than a single fit [126].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Data Acquisition and Analysis
What the sources say
- Not checked yetcites [126] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Beyond primary sequence coverage, MS/MS analysis has been utilized to study protein complexes [122] and protein-ligand binding [123].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Recently, FLASHDeconv used pattern matching to quickly deconvolute MS with speeds orders of magnitudes higher than conventional approaches [128].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Data Acquisition and Analysis
What the sources say
- Not checked yetcites [128] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“For example, Gault et al. demonstrated the use of MS4 analysis to identify both the proteoform state and the associated ligand structure [123].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Protein Fragmentation for Sequence Determination
What the sources say
- Not checked yetcites [123] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Hypertrophic cardiomyopathy is a commonly heritable cardiovascular disease that results in the thickening of the ventricular septum, which results in obstructive heart failure if left untreated [147].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Not checked yetcites [147] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“recently the Ge group developed MASH Explorer, which integrates multiple spectral deconvolution and database searching algorithms into a single, freely-available universal platform that can process top-down proteomics data from various vendor formats [139].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Data Acquisition and Analysis
What the sources say
- Not checked yetcites [139] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“MS-based proteomics has become a staple in biomedical research for the discovery of novel biomarkers and elucidation of disease mechanisms [140].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Not checked yetcites [140] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“While around 1,400 mutations have been identified in 11 genes related to the sarcomere, the molecular events leading to disease phenotype remain largely misunderstood [148].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Not checked yetcites [148] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“For example, in the heart, protein isoform switching [141], and PTMs are known to regulate cardiac contraction and relaxation, as well as play a role in the progression of heart failure [61,142,143].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, the authors determined a strong linear correlation of decreased phosphorylation levels of cardiac troponin I and enigma homolog 2 in the HCM samples suggesting protein crosstalk or dysregulation of signaling by cAMP-dependent protein kinase A (Figure 4) [149].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Not checked yetcites [149] source
hedgedcorrelationaln = 16- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“While patient tissue samples are the most relevant for disease studies, human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer unprecedented clinical opportunities to study heritable cardiovascular diseases, test various drug candidates, and enable cardiac regeneration and precision medicine [150].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Not checked yetcites [150] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Patient tissue samples are the most relevant for disease studies.
In the paper
“Quantitative top-down proteomics discovered that there were distinct differences in the myofilament proteoforms found across the seven various rat skeletal muscle tissues, which demonstrates the highly heterogeneous nature of skeletal muscle (Figure 6) [154].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
- Not checked yetcites [154] source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
None of the sources cited for this claim have been checked yet.
In the paper
“A range of clinical samples including serum, urine, or biopsy tissue, have been studied using top-down proteomics to identify protein profiles characteristic of a certain disease generating a more reliable biomarker [155–157].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“For example, analysis of antibodies by top-down can quickly determine the modification state [81], drug conjugate ratio [161], quality control screening [162], and more [163,164].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Application in Disease Research
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
Many diseases have complex molecular mechanisms that remain poorly understood.
“However, many challenges remain to unravel the complex nature of diseases.”
The paper relies on this without support.
Improved understanding of disease mechanisms is necessary for developing more effective diagnostics and therapeutics for precision medicine.
“A better understanding of the underlying molecular mechanism of diseases is critical for developing more effective diagnostic tools and therapeutics towards precision medicine.”
The paper relies on this without support.
hiPSC-CMs resemble fetal cardiomyocytes rather than fully matured cardiomyocytes.
“However, a major limitation to hiPSC-CM resembles fetal CMs rather than fully matured CMs.”
The paper relies on this without support.
There is a lack of comprehensive methods to measure the maturity of hiPSC-CMs.
“In addition, there is a lack of comprehensive methods to measure the maturity of hiPSC-CMs.”
The paper relies on this without support.
There remains an incomplete understanding of the molecular mechanism underlying sarcopenia.
“However, there remains an incomplete understanding of the molecular mechanism underlying sarcopenia.”
The paper relies on this without support.
Patient tissue samples are the most relevant for disease studies.
“While patient tissue samples are the most relevant for disease studies, human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer unprecedented clinical opportunities to study heritable cardiovascular diseases, test various drug candidates, and enable cardiac regeneration and precision medicine [150].”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the past decade, TDP has gained momentum, but limitations in protein separation and coverage of large proteoforms (>30 kDa) are still present (19).”
From The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells (2022) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > Methods for Top-down Proteomics > Intact Protein Separation
“In 2012, the Kelleher group combined solution isoelectric focusing, GELFrEE, and RPLC-MS/MS to identify ~3,000 proteoforms from 1043 protein groups including proteins up to 105 kDa [84].”
§ Top-down Proteomics: Challenges, Innovations, and Applications in Basic and Clinical Research > References
“84. Tran JC, Zamdborg L, Ahlf DR Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature, 480(7376), 254– 258 (2011).”
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Electrospray Ionization for Mass Spectrometry of Large Biomolecules
Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., & Whitehouse, C. M. (1989) · Science · doi:10.1126/science.2675315 · Cited by 7,634
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
Washburn, M. P., Wolters, D. A., & Yates, J. R. (2001) · Nature Biotechnology · doi:10.1038/85686 · Cited by 4,768
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry
Syka, J. E. P., Coon, J. J., Schroeder, M. J., Shabanowitz, J., & Hunt, D. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402700101 · Cited by 2,370
Electron Capture Dissociation of Multiply Charged Protein Cations. A Nonergodic Process
Zubarev, R. A., Kelleher, N. L., & McLafferty, F. W. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973478k · Cited by 1,881
Proteoform: a single term describing protein complexity
The Consortium for Top Down Proteomics, Smith, L. M., & Kelleher, N. L. (2013) · Nature Methods · doi:10.1038/nmeth.2369 · Cited by 1,528
Research works printed but not linked: 5
- 10.1002/pro.5560031109 · DOI · Paper page
- 10.1021/cr068286z · DOI · Paper page
- Anderson NL, 2002, History Charact Diagn Prospects, 1, 845
- 10.1021/pr200258m · DOI · Paper page
- 10.1080/14789450.2016.1209414 · DOI · Paper page
Cited by
Sorted by citations
Novel Strategies to Address the Challenges in Top-Down Proteomics
Melby, J. A., Roberts, D. S., Larson, E. J., Brown, K. A., Bayne, E. F., Jin, S., & Ge, Y. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.1c00099 · Cited by 201
Self-citationRoberts, D. S., Loo, J. A., Tsybin, Y. O., Liu, X., Wu, S., Chamot-Rooke, J., Agar, J. N., Paša-Tolić, L., Smith, L. M., & Ge, Y. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00318-2 · Cited by 161
Self-citationThe Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells
Melani, R. D., Gerbasi, V. R., Anderson, L. C., Sikora, J. W., Toby, T. K., Hutton, J. E., Butcher, D. S., Negrão, F., Seckler, H. S., Srzentić, K., et al. (2022) · Science · doi:10.1126/science.aaz5284 · Cited by 140
Top-Down Proteomics and the Challenges of True Proteoform Characterization
Po, A., & Eyers, C. E. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00416 · Cited by 117
Impact of novel detergents on membrane protein studies
Lee, H. J., Lee, H. S., Youn, T., Byrne, B., & Chae, P. S. (2022) · Chem · doi:10.1016/j.chempr.2022.02.007 · Cited by 96
Dowling, P., Gargan, S., Swandulla, D., & Ohlendieck, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032415 · Cited by 103
Proteomics, Personalized Medicine and Cancer
Su, M., Zhang, Z., Zhou, L., Han, C., Huang, C., & Nice, E. C. (2021) · Cancers · doi:10.3390/cancers13112512 · Cited by 93
Instrumentation at the Leading Edge of Proteomics
Peters-Clarke, T. M., Coon, J. J., & Riley, N. M. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04497 · Cited by 89
Investigating Toxin Diversity and Abundance in Snake Venom Proteomes
Tasoulis, T., Pukala, T., & Isbister, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768015 · Cited by 77
Roberts, D. S., Mann, M. W., Melby, J. A., Larson, E. J., Zhu, Y., Brasier, A. R., Jin, S., & Ge, Y. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c02713 · Cited by 75
Self-citationHigh sensitivity top–down proteomics captures single muscle cell heterogeneity in large proteoforms
Melby, J. A., Brown, K. A., Gregorich, Z. R., Roberts, D. S., Chapman, E. A., Ehlers, L. E., Gao, Z., Larson, E. J., Jin, Y., Lopez, J. R., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2222081120 · Cited by 72
Self-citationToward single-molecule protein sequencing using nanopores
Lu, C., Bonini, A., Viel, J. H., & Maglia, G. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02587-y · Cited by 68
Liu, R., Xia, S., & Li, H. (2022) · Mass Spectrometry Reviews · doi:10.1002/mas.21793 · Cited by 64
TopFD: A Proteoform Feature Detection Tool for Top–Down Proteomics
Basharat, A. R., Zang, Y., Sun, L., & Liu, X. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05244 · Cited by 63
Critical considerations in N-glycoproteomics
Chau, T. H., Chernykh, A., Kawahara, R., & Thaysen‐Andersen, M. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102272 · Cited by 58
Recent advances in top‐down proteome sample processing ahead of MS analysis
Nickerson, J. L., Baghalabadi, V., Rajendran, S. R. C. K., Jakubec, P. J., Said, H., McMillen, T. S., Dang, Z., & Doucette, A. A. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21706 · Cited by 57
Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade
Lill, J. R., Mathews, W. R., Rose, C. M., & Schirle, M. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1962300 · Cited by 57
Xu, T., Wang, Q., Wang, Q., & Sun, L. (2024) · Analytical Methods · doi:10.1039/d4ay00651h · Cited by 54
Food allergen detection by mass spectrometry: From common to novel protein ingredients
Bianco, M., Ventura, G., Calvano, C. D., Losito, I., & Cataldi, T. R. I. (2023) · PROTEOMICS · doi:10.1002/pmic.202200427 · Cited by 56
Top-down mass spectrometry of native proteoforms and their complexes: a community study
Habeck, T., Brown, K. A., Soye, B. J. D., Lantz, C., Zhou, M., Alam, N., Hossain, M. A., Jung, W., Keener, J. E., Volný, M., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02279-6 · Cited by 52
Self-citationCollision energies: Optimization strategies for bottom‐up proteomics
Révész, Á., Hevér, H., Steckel, A., Schlosser, G., Szabo, D. A., Vékey, K., & Drahos, L. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21763 · Cited by 46
Štěpánová, S., & Kašička, V. (2023) · Journal of Separation Science · doi:10.1002/jssc.202300043 · Cited by 41
Native top-down proteomics enables discovery in endocrine resistant breast cancer
Gomes, F. P., Durbin, K. R., Schauer, K. L., Nwachukwu, J., Kobylski, R. R., Njeri, J., Seath, C. P., Saviola, A. J., McClatchy, D. B., Diedrich, J. K., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01866-8 · Cited by 34
The application of proteomics in muscle exercise physiology
Hesketh, S. J., Stansfield, B. N., Stead, C. A., & Burniston, J. G. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1879647 · Cited by 34
Kline, J. T., Belford, M. W., Boeser, C. L., Huguet, R., Fellers, R. T., Greer, J. B., Greer, S. M., Horn, D. M., Durbin, K. R., Dunyach, J., et al. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00488 · Cited by 35
Zhao, Z., Guo, Y., Chowdhury, T., Anjum, S., Li, J., Huang, L., Cupp‐Sutton, K. A., Burgett, A. W. G., Shi, D., & Wu, S. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01119 · Cited by 31
Roberts, D. S., Mann, M. W., Li, B. H., Kim, D., Braiser, A. R., Jin, S., & Ge, Y. (2022) · Chemical Science · doi:10.1039/d2sc02132c · Cited by 29
Self-citationMass Spectrometry Strategies for O-Glycoproteomics
Helms, A., & Brodbelt, J. S. (2024) · Cells · doi:10.3390/cells13050394 · Cited by 29
Emerging chemistry and biology in protein glutathionylation
Kukulage, D. S. K., Don, N. N. J. M., & Ahn, Y. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2022.102221 · Cited by 30
Multidimensional separations in top–down proteomics
Guo, Y., Cupp‐Sutton, K. A., Zhao, Z., Anjum, S., & Wu, S. (2023) · Analytical Science Advances · doi:10.1002/ansa.202300016 · Cited by 28
Sadeghi, S. A., Chen, W., Wang, Q., Wang, Q., Fang, F., Liu, X., & Sun, L. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00872 · Cited by 26
Bondt, A., Dingess, K. A., Hoek, M., van Rijswijck, D. M. H., & Heck, A. J. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.789748 · Cited by 23
The ubiquitin proteoform problem
Deol, K. K., & Strieter, E. R. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.02.015 · Cited by 22
Tabang, D. N., Ford, M., & Li, L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.707387 · Cited by 24
One-Pot Exosome Proteomics Enabled by a Photocleavable Surfactant
Buck, K. M., Roberts, D. S., Aballo, T. J., Inman, D. R., Jin, S., Ponik, S. M., Brown, K. A., & Ge, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01252 · Cited by 23
Self-citationJeong, K., Babović, M., Gorshkov, V., Kim, J., Jensen, O. N., & Kohlbacher, O. (2022) · Nature Communications · doi:10.1038/s41467-022-31922-z · Cited by 25
Sung, C. H., Hao, T., Fang, H., Nguyen, A. T., Perricone, V., Yu, H., Huang, W., Sarmiento, E., Ornelas, A. F. D., Lublin, D., et al. (2025) · Advanced Materials · doi:10.1002/adma.202509281 · Cited by 21
Decoding alternative splicing: A key player in plant biotic stress resistance
Zhu, J., Guo, W., Chen, J., & Sun, Z. (2025) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13951 · Cited by 18
Exploring the unmapped cysteine redox proteoform landscape
Cobley, J. N. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00152.2024 · Cited by 23
Chowdhury, T., Cupp‐Sutton, K. A., Guo, Y., Gao, K., Zhao, Z., Burgett, A. W. G., & Wu, S. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00778 · Cited by 18
PEPPI-MS: gel-based sample pre-fractionation for deep top-down and middle-down proteomics
Takemori, A., Kaulich, P. T., Tholey, A., & Takemori, N. (2025) · Nature Protocols · doi:10.1038/s41596-024-01100-0 · Cited by 17
Wang, C., Liang, Y., Zhao, B., Liang, Z., Zhang, L., & Zhang, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c05234 · Cited by 17
Bayne, E. F., Rossler, K. J., Gregorich, Z. R., Aballo, T. J., Roberts, D. S., Chapman, E. A., Guo, W., Palecek, S. P., Ralphe, J. C., Kamp, T. J., et al. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.06.003 · Cited by 16
Self-citationSearfoss, R. M., Zahn, E., Lin, Z., & Garcia, B. A. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00874 · Cited by 19
Chromatographic separation of peptides and proteins for characterization of proteomes
Liang, Y., Zhang, L., & Zhang, Y. (2022) · Chemical Communications · doi:10.1039/d2cc05568f · Cited by 17
Greenness of proteomic sample preparation and analysis techniques for biopharmaceuticals
Maráková, K., Tomašovský, R., Opetová, M., & Schug, K. A. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117490 · Cited by 15
Kumar, N. H., Kluever, V., Barth, E., Krautwurst, S., Furlan, M., Pelizzola, M., Marz, M., & Fornasiero, E. F. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae172 · Cited by 15
Nonionic, Cleavable Surfactant for Top-Down Proteomics
Brown, K. A., Gugger, M. K., Yu, Z., Moreno, D., Jin, S., & Ge, Y. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03916 · Cited by 15
Self-citationRahali, M. A., Lakis, R., Sauvage, F., Pinault, É., Marquet, P., Saint‐Marcoux, F., & Balkhi, S. E. (2023) · Journal of Chromatography B · doi:10.1016/j.jchromb.2023.123740 · Cited by 14
Berthias, F., Bilgin, N., Mecinović, J., & Jensen, O. N. (2024) · PROTEOMICS · doi:10.1002/pmic.202200471 · Cited by 14
Spatial -omics technologies: the new enterprise in 3D breast cancer models
Pierantoni, L., Reis, R. L., Silva‐Correia, J., Oliveira, J. M., & Heavey, S. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.07.003 · Cited by 12
A Universal Spectrum Annotator for Complex Peptidoforms in Mass Spectrometry-Based Proteomics
Schulte, D., Leuvenink, R. W., Jager, S., Heck, A. J. R., & Snijder, J. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02832 · Cited by 12
Miles, H. N., Delafield, D. G., & Li, L. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00039j · Cited by 12
Identification of Subproteomic Markers for Skeletal Muscle Profiling
Dowling, P., Gargan, S., Swandulla, D., & Ohlendieck, K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2831-7_20 · Cited by 12
Mass spectrometry based proteomics: Changing the impact of protein analysis in forensic science
Keane, R. E., Tidy, R. J., Parker, G. J., Gummer, J. P. A., & Priddis, C. (2024) · Wiley Interdisciplinary Reviews Forensic Science · doi:10.1002/wfs2.1516 · Cited by 14
Progress in Tandem Mass Spectrometry Data Analysis for Nucleic Acids
Lanzillotti, M. B., & Brodbelt, J. S. (2025) · Mass Spectrometry Reviews · doi:10.1002/mas.21923 · Cited by 12
Abbas, T., Kanwar, F., Tariq, H., & Malik, M. R. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i1.507 · Cited by 11
Top-Down Proteomics and Comparative 2D-DIGE Analysis
Ohlendieck, K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2831-7_2 · Cited by 11
Mass spectrometry-based proteomics for advancing solid organ transplantation research
Huang, C., Su, P., Fisher, T. D., Levitsky, J., Kelleher, N. L., & Forte, E. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1286881 · Cited by 10
Wang, C. R., Harlington, A. C., Snel, M. F., & Pukala, T. L. (2023) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2023.140992 · Cited by 10
A Conformation-Specific Approach to Native Top-down Mass Spectrometry
Britt, H. M., Ben-Younis, A., Page, N., & Thalassinos, K. (2024) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.4c00361 · Cited by 10
Brown, K. A., Morris, R. K., Eckhardt, S. J., Ge, Y., & Gellman, S. H. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09078 · Cited by 10
Self-citationArad, M., Frey, C., Balagtas, R., Hare, R., Ku, K., Jereb, D., Nestman, Z., Sidhu, A., Shi, Y., Fordwour, O. B., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04846 · Cited by 9
Exploring snake venoms beyond the primary sequence: From proteoforms to protein-protein interactions
Wang, C. R., McFarlane, L. O., & Pukala, T. L. (2024) · Toxicon · doi:10.1016/j.toxicon.2024.107841 · Cited by 9
Ni, W., Jagust, W. J., & Wang, D. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00424 · Cited by 9
Size Exclusion Chromatography Strategies and MASH Explorer for Large Proteoform Characterization
Tiambeng, T. N., Wu, Z., Melby, J. A., & Ge, Y. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2325-1_3 · Cited by 10
Self-citationLuo, R. Y., Pfaffroth, C., Yang, S., Hoang, K., Yeung, P. S.-W., Zehnder, J. L., & Shi, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-42064-7 · Cited by 9
Lieu, L. B., Hinkle, J. D., Syka, J. E. P., & Fornelli, L. (2024) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.4c00391 · Cited by 8
Liu, H., Huang, S., Yang, L., He, Y., Jing, Y., Xie, Y., Hu, B., Li, Z., Bi, H., & Li, Z. (2025) · Talanta · doi:10.1016/j.talanta.2025.128611 · Cited by 8
How can we use proteomics to learn more about platelets?
Aslan, J. E. (2023) · Platelets · doi:10.1080/09537104.2023.2217932 · Cited by 8
Fulcher, J. M., Swensen, A., Chen, Y., Verchere, C. B., Petyuk, V., & Qian, W. (2023) · Endocrinology · doi:10.1210/endocr/bqad160 · Cited by 8
Use of dried blood spots for monitoring inflammatory and nutritional biomarkers in the elderly
Vialaret, J., Vignon, M., Hirtz, C., Badiou, S., Baptista, G., Fichter, L., Dupuy, A., Maceski, A. M., Fayolle, M., Brousse, M., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0312 · Cited by 9
Absolute quantification of proteins using element mass spectrometry and generic standards
Nosti, A. J., Cid-Barrio, L., Calderón‐Celis, F., Soldado, A., & Encinar, J. R. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104499 · Cited by 10
Cline, E. N., Alvarez, C., Duan, J., & Patrie, S. M. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00396 · Cited by 8
Brown, K. A., Anderson, C. L., Reilly, L., Sondhi, K., Ge, Y., & Eckhardt, L. L. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00555 · Cited by 7
Self-citationAthira Raj, T., Aravind, G. B., Arun, M., & Aneesh, E. M. (2025) · Egyptian Journal of Forensic Sciences · doi:10.1186/s41935-025-00484-8 · Cited by 7
Post‐translational Modifications in Proteins: Prediction Methods, Biological Functions, and Diseases
Zhang, S., li, J., Chen, M., & Huang, H. (2026) · MedComm · doi:10.1002/mco2.70729 · Cited by 9
TopDIA: A Software Tool for Top-Down Data-Independent Acquisition Proteomics
Basharat, A. R., Xiong, X., Xu, T., Zang, Y., Sun, L., & Liu, X. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00293 · Cited by 9
Wilson, M. C., Josvai, M. B., Walters, J. K., Lawson, J., Rossler, K. J., Gao, Z., Zhu, Y., Kamp, T. J., Crone, W. C., Eckhardt, L. L., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00505 · Cited by 6
Self-citationApplications of high performance liquid chromatography-mass spectrometry in proteomics
Wei, L. I. U., Weng, L., Gao, M., & Zhang, X. (2024) · Chinese Journal of Chromatography · doi:10.3724/sp.j.1123.2023.11006 · Cited by 6
Ni, Z., & Arévalo, R. (2024) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9887 · Cited by 6
FLASHQuant: A Fast Algorithm for Proteoform Quantification in Top-Down Proteomics
Kim, J., Jeong, K., Kaulich, P. T., Winkels, K., Tholey, A., & Kohlbacher, O. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03117 · Cited by 6
Unravelling disease complexity: integrative analysis of multi-omic data in clinical research
Cominetti, O., & Dayon, L. (2025) · Expert Review of Proteomics · doi:10.1080/14789450.2025.2491357 · Cited by 7
Bashyal, A., Dunham, S. D., & Brodbelt, J. S. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c02618 · Cited by 5
A Narrative Review of the Role of S-Glutathionylation in Bacteria
Federici, L., Masulli, M., Laurenzi, V. D., & Allocati, N. (2025) · Microorganisms · doi:10.3390/microorganisms13030527 · Cited by 5
Selective Comprehensive Online NanoLCxCZE-MS Platform for Top-Down Proteoform Analysis
Waldmann, T., Kaulich, P. T., Stolz, A., Tholey, A., & Neusüß, C. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03469 · Cited by 4
Ayon, N. J. (2025) · AppliedChem · doi:10.3390/appliedchem5040035 · Cited by 6
Gao, Z., Rossler, K. J., Rogers, H. T., Gregorich, Z. R., Aballo, T. J., Chapman, E. A., Price, S. J., Hermsen, J. L., de Lange, W. J., Zhu, Y., et al. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.012899 · Cited by 6
Self-citationFull Window Data-Independent Acquisition Method for Deeper Top-Down Proteomics
Sun, C., Zhang, W., Zhou, M., Myu, M., & Xu, W. L. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06471 · Cited by 6
Accurate Proteoform Identification and Quantitation Using pTop 2.0
Sun, R.-X., Wang, R., Luo, L. E., Liu, C., Chi, H., Zeng, W., & He, S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2325-1_9 · Cited by 7
The World of Protein Interactions
Eyk, J. E. V. (2021) · Circulation Research · doi:10.1161/circresaha.121.318922 · Cited by 5
Dollar, A. N., & Webb, I. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03978 · Cited by 4
Characterization of Cytokine Treatment on Human Pancreatic Islets by Top‐Down Proteomics
Ives, A. N., Sagendorf, T. J., Nierves, L. A., Lin, T., Dirice, E., Kulkarni, R. N., Paša‐Tolić, L., Qian, W., & Fulcher, J. M. (2025) · PROTEOMICS · doi:10.1002/pmic.70044 · Cited by 5
Cupp‐Sutton, K. A., Guo, Y., Welborn, T., & Wu, S. (2025) · Journal of Mass Spectrometry · doi:10.1002/jms.5187 · Cited by 4
Methionine Oxidation Footprinting in Intact Proteins (MOFIP) Using Top‐Down Proteomics
Sunny, A. T., Cupp‐Sutton, K. A., Zhao, Z., Chowdhury, T., Guo, Y., & Wu, S. (2025) · PROTEOMICS · doi:10.1002/pmic.70063 · Cited by 4
Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?
Giuliani, P., Simone, C. D., Febo, G., Bellasame, A., Tupone, N., Virglio, V. D., Giuseppe, F. D., Ciccarelli, R., Iorio, P. D., & Angelucci, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189778 · Cited by 4
Fartade, S., Jadav, T., Rajput, N., & Sengupta, P. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.202400911 · Cited by 3
Wilson, M. C., Gao, Z., Lopez, J. R., Zhu, Y., Olszewski, S. S., Konopka, A. R., Diffee, G. M., & Ge, Y. (2026) · Journal of Mass Spectrometry · doi:10.1002/jms.70040 · Cited by 3
Self-citationYue, Y., Fang, F., Gao, G., Sadeghi, S. A., Colón-Rosado, J. A., Nimavard, R. T., Askarani, M. F., Thorp, L., Dashtaki, M. R., Zhu, G., et al. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c01194 · Cited by 3
Exploiting ion‐mobility mass spectrometry for unraveling proteome complexity
Perchepied, S., Zhou, Z., Mitulović, G., & Eeltink, S. (2023) · Journal of Separation Science · doi:10.1002/jssc.202300512 · Cited by 3
Metadata
- Authors
- Brown, K. A., Melby, J. A., Roberts, D. S., & Ge, Y.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Brown, Kyle A.
- Ge, Ying
- Venue
- Expert Review of Proteomics
- Publisher
- Informa UK Limited
- Published
- 2020-10-02
- Volume
- 17
- Issue
- 10
- Pages
- 719-733
- ISSN
- 1478-9450 (ISSN-L)
- 1744-8387
- PMC
- PMC7864889
- OpenAlex
- W3106602244
- Cited by
- 152
- References
- 163
- Citations by year
- 2026: 23 · 2025: 37 · 2024: 28 · 2023: 26 · 2022: 19 · 2021: 18 · 2020: 1
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Expert Review of Proteomics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Foundation for the National Institutes of Health
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- top-down proteomics, proteoforms, protein isoforms, post-translational modification, alternative splicing, heart disease, precision medicine, sample preparation, intact protein separation
- MeSH terms
- Heart Diseases, Humans, Protein Processing, Post-Translational, Proteomics, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review